Expert Review of Vaccines logo Expert Reviews logo

Expert Review of Vaccines provides expert reviews on the clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines in bioterrorism.

Publisher: Expert Reviews

Volume 8, Number 6, June 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial

Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges
pp. 655-658(4)
Author: Murphy, Timothy F

News in brief

News in brief
pp. 659-661(3)

Vaccine Profile

Review of 8 years of experience with Infanrix hexa™ (DTPa-HBV-IPV/Hib hexavalent vaccine)
pp. 663-678(16)
Authors: Zepp, Fred; Schmitt, Heinz-Josef; Cleerbout, Jan; Verstraeten, Thomas; Schuerman, Lode; Jacquet, Jeanne-Marie

Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines)
pp. 679-688(10)
Authors: Doroshenko, Alexander; Halperin, Scott A

Key Paper Evaluation

Protective immunity to influenza: lessons from the virus for successful vaccine design
pp. 689-693(5)
Authors: Garulli, Bruno; Castrucci, Maria R

Pneumococcal conjugate vaccination and otitis media: differences among high-risk and low-risk populations
pp. 695-698(4)
Author: Nascimento-Carvalho, Cristiana Maria

Detailed analysis for inducing specific CD8 T cells via a CpG-DNA adjuvant
pp. 699-703(5)
Authors: Eguchi, Masahiro; Watanabe, Mineo

Perspective

Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS
pp. 705-716(12)
Authors: Autran, Brigitte; Asturias, Edwin J; Evans, Stephen; Hartigan-Go, Kenneth; Hussey, Gregory; John, T Jacob; Lambert, Paul-Henri; Law, Barbara; Midthun, Karen; Nohynek, Hanna; Salmaso, Stefania; Smith, Peter G; Zuber, Patrick LF; Bentsi-Enchill, Adwoa; Caric, Aleksandra; Pfeifer, Dina; Duclos, Philippe; Wood, David

Review

Expanding prevention of invasive meningococcal disease
pp. 717-727(11)
Authors: Pelton, Stephen I; Gilmet, Gregory P

Challenges and progress in the development of a serogroup B meningococcal vaccine
pp. 729-745(17)
Authors: Lewis, Susan; Sadarangani, Manish; Hoe, J Claire; Pollard, Andrew J

Moving forward: a mucosal vaccine against group A streptococcus
pp. 747-760(14)
Authors: Georgousakis, Melina M; McMillan, David J; Batzloff, Michael R; Sriprakash, Kadaba S

Strategies to overcome host immunity to adenovirus vectors in vaccine development
pp. 761-777(17)
Authors: Thacker, Erin E; Timares, Laura; Matthews, Qiana L

Flow cytometry and the future of vaccine development
pp. 779-789(11)
Authors: Bolton, Diane L; Roederer, Mario

Current status of toxoplasmosis vaccine development
pp. 791-808(18)
Authors: Kur, Józef; Holec-Gąsior, Lucyna; Hiszczyńska-Sawicka, Elżbieta

Acknowledgements

Acknowledgements
pp. 817-817(1)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A